The global non-invasive blood glucose monitoring devices market, By Technology (Optical, Transdermal, Enzymatic, and Others), By Modality (Wearable, and Non-wearable), By End User (Hospitals, Home Care Settings, and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was pegged at US$ 5.1 million in 2017, and is projected to witness a staggering 35.0% CAGR over the forecast period (2018-2026).
Surging global prevalence of diabetes and increasing R&D activities by various key players in the market to develop and launch innovative, cost-effective devices are among the pivotal factors expected to boost the growth of the global non-invasive blood glucose monitoring market.
Browse Research Report: https://www.coherentmarketinsights.com/market-insight/non-invasive-blood-glucose-monitoring-devices-market-1480
According to the International Diabetes Federation (IDF) Diabetes Atlas: 2017, number of diabetic patients worldwide, aged between 20 years and 79 years, was valued at 425 million, which is estimated to increase by 48% in 2045. The key players are increasingly implementing inorganic growth strategies in order to gain a competitive edge in the global. For instance, in July 2018, Metamaterial Technologies Inc. acquired Medical Wireless Sensing Ltd. (MediWiSe). MediWiSe, for the record, has made significant advancements in non-invasive glucose monitoring and is working towards the development of a new product, called Glucowise.
Non-invasive glucose monitoring is known to offer painless, risk-free, low-cost and frequent testing of glucose, and the tests majorly include the reverse iontophoresis method, optics-related method, metabolic heat conformation method, and bio-impedance spectroscopy method among others. Owing to the complexity of human body composition and physiological processes, no single non-invasive method can achieve the reliable test results alone. Therefore, researchers are conducting studies on integration of multiple methods, which have become a major trend for research on non-invasive glucose monitoring.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1480
• Based on modality, the non-wearable segment is expected to account for a major market share by 2026. Increasing R&D activities by key players, combined with growing investor funding to back the research is expected to drive growth of the segment.
• The renowned players operating in the global non-invasive blood glucose monitoring devices market include DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
• These players have been developing non-invasive devices, which integrate more than two detection methods. For instance, Glucotrack, a non-invasive intermittent glucose monitoring device for home-use, uses a combination of three technologies (ultrasonic, electromagnetic, and thermal) with a unique algorithm to weigh each measurement and calculate the weighted average of the three readings.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1480
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737